Acetaminophen does not lower blood pressure. For decades, many people assumed it was a blood-pressure-neutral alternative to ibuprofen and other painkillers, but a randomized clinical trial published in Circulation found that regular acetaminophen use actually raised systolic blood pressure by roughly 5 mmHg in people who already had hypertension. That increase is clinically meaningful and challenges a widely held belief among both patients and prescribers.
Where the Assumption Came From
The idea that acetaminophen is gentler on the cardiovascular system than other over-the-counter painkillers has been around for a long time. Nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen have well-documented effects on blood pressure and kidney function, so guidelines often steered patients with hypertension or heart disease toward acetaminophen instead. The logic seemed straightforward: acetaminophen works differently from NSAIDs, so it should be safer for the heart and blood vessels.
Before 2022, this recommendation rested almost entirely on observational data and the absence of a rigorous trial testing the assumption directly. Some large observational studies had hinted that regular acetaminophen use might be linked to higher blood pressure, but observational findings can be muddied by confounders. People who take acetaminophen every day tend to have chronic pain conditions, and chronic pain itself can affect blood pressure. Without a placebo-controlled trial, the picture stayed murky for years.1Circulation. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial – Section: BACKGROUND
The PATH-BP Trial Changed the Conversation
The PATH-BP trial, published in 2022, was the first randomized, double-blind, placebo-controlled crossover trial designed specifically to answer whether regular acetaminophen affects blood pressure in people with hypertension. Participants took 1 gram of acetaminophen four times daily (a standard full dose for chronic pain) for two weeks, then switched to a matching placebo for two weeks, with a washout period in between.
The results were unambiguous. During the acetaminophen phase, average daytime systolic blood pressure rose by about 4 points, while average daytime diastolic blood pressure rose by about 1.5 points, compared to placebo. The placebo-corrected increase in systolic pressure was close to 5 mmHg.2Circulation. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial – Section: Results
To someone who does not think about blood pressure numbers daily, a 5-point rise might sound trivial. It is not. Population-level data suggest that a sustained increase of this size raises the risk of heart attack and stroke meaningfully over time. In fact, some blood pressure medications are considered worth prescribing precisely because they can lower systolic pressure by that same margin. So acetaminophen, at full chronic dosing, was working against blood pressure control by roughly the magnitude of a medication designed to improve it.
Why Regular Use Matters More Than Occasional Use
An important distinction in the PATH-BP trial is that participants were taking a full therapeutic dose four times a day for two straight weeks. That is the kind of regimen someone with chronic low back pain, osteoarthritis, or persistent headaches might follow. It is not the same as popping two tablets for a one-off headache.
The trial did not study occasional or short-term use, so the findings should not be extrapolated to someone who takes acetaminophen once or twice a month. The blood pressure increase emerged during sustained daily dosing. If you reach for acetaminophen a handful of times a year when you have a fever or a sore muscle, the evidence from this trial does not apply to you in the same way. The concern centers on people who use it daily or near-daily, which is common among those managing chronic pain.
That said, the line between “occasional” and “regular” can blur. Someone who starts taking acetaminophen for a flare-up may drift into taking it every day without really thinking of themselves as a chronic user. If you find yourself reaching for it most days of the week, the trial’s findings become relevant.
How Acetaminophen May Raise Blood Pressure
Researchers have proposed several biological pathways that could explain why regular acetaminophen bumps blood pressure up, though no single mechanism has been definitively confirmed. One leading idea involves the same enzyme system that NSAIDs target. Acetaminophen appears to inhibit cyclooxygenase enzymes in the central nervous system and blood vessel walls, which reduces the production of prostaglandins that normally help blood vessels relax. With fewer of those vasodilating signals around, blood vessels tighten and resistance goes up.3AHA Journals. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension
Another proposed route involves oxidative stress. When the body breaks down acetaminophen, the process generates reactive oxygen species, which are chemically aggressive molecules that can damage the inner lining of blood vessels. That damage impairs the vessels’ ability to produce nitric oxide, a key molecule that tells smooth muscle in artery walls to relax. Less nitric oxide means stiffer, narrower vessels and higher pressure.
A third possibility involves the kidneys. Some evidence suggests acetaminophen may promote sodium and water retention through effects on renal function, which increases blood volume and therefore pressure. There is also speculation about changes in the autonomic nervous system, the unconscious control system that regulates heart rate and vessel tone. The honest answer is that researchers are still sorting out which of these pathways matters most, and the effect is probably a combination of several.
Acetaminophen Versus NSAIDs for Blood Pressure
For years, the standard advice for people with high blood pressure was to avoid NSAIDs and use acetaminophen instead. NSAIDs raise blood pressure through well-understood mechanisms involving prostaglandin inhibition in the kidneys, leading to fluid retention and increased vascular resistance. The assumption was that acetaminophen, because it works primarily in the central nervous system rather than peripherally, would sidestep those cardiovascular effects.
That assumption has weakened considerably. Recent evidence indicates that acetaminophen, much like most NSAIDs, does increase blood pressure.4Lippincott Williams & Wilkins. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension The magnitude of the increase seen in the PATH-BP trial is comparable to what some NSAID trials have reported, though head-to-head comparisons in the same study remain limited. Acetaminophen formulations that contain sodium, such as effervescent tablets, may carry additional cardiovascular risk on top of the drug’s own effect because the sodium contributes to fluid retention independently.
This does not mean NSAIDs and acetaminophen are equally risky in every respect. NSAIDs still carry additional concerns around gastrointestinal bleeding, kidney injury, and platelet function that acetaminophen largely avoids. But the old framing of acetaminophen as “the safe one for your heart” no longer holds up. The choice between the two is more nuanced than it used to be, and neither option is truly benign when used regularly.
Who Should Be Most Concerned
The PATH-BP trial enrolled people who already had hypertension, so the strongest evidence applies to that group. If your blood pressure is already elevated or you are taking medication to control it, adding daily acetaminophen could partially undo the benefit of your treatment. A 5 mmHg increase in systolic pressure might push you from well-controlled into a range where your doctor would consider adjusting your medication.
People at increased cardiovascular risk deserve particular caution. The clinical perspective accompanying the PATH-BP trial explicitly recommended that prescribers think carefully before recommending acetaminophen to patients with elevated cardiovascular risk and consider opportunities to stop the drug or reduce the dose.5Circulation. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial – Section: Clinical Perspective That includes people with a history of heart attack, stroke, heart failure, or kidney disease, as well as those with multiple risk factors like diabetes and high cholesterol.
For younger adults with normal blood pressure and no cardiovascular risk factors, the implications are less clear. The trial did not study that population directly, and a temporary small bump in blood pressure in someone starting from a healthy baseline is a very different situation from the same bump in someone whose pressure is already borderline. Still, anyone taking acetaminophen daily for weeks or months should be aware that it is not the pressure-neutral drug it was once believed to be.
Practical Steps If You Rely on Acetaminophen
If you use acetaminophen regularly, especially for chronic pain, there are a few things worth considering. First, talk to your doctor about whether the dose can be reduced. Many people default to the maximum recommended dose out of habit when a lower dose might provide adequate relief with a smaller physiological footprint. Second, if you monitor your blood pressure at home, pay attention to whether your readings creep up during periods of heavy acetaminophen use. That kind of pattern is easy to miss if you are not looking for it.
Third, consider whether non-drug approaches might help reduce how often you need a painkiller at all. Physical therapy, exercise, heat and cold therapy, and cognitive behavioral therapy for pain have all shown benefit for common chronic pain conditions. These approaches do not raise blood pressure and, in the case of exercise, actively lower it. They may not eliminate the need for acetaminophen entirely, but reducing the number of days per week you take it changes your risk profile.
Finally, check the labels of combination products. Acetaminophen is an ingredient in a surprisingly large number of cold, flu, sinus, and sleep medications. If you are taking one of those products daily on top of standalone acetaminophen, you could be getting a higher total dose than you realize, which matters both for blood pressure and for liver safety.
The Sodium Factor in Effervescent Formulations
One detail that often gets lost in the broader conversation is the role of sodium in certain acetaminophen products. Effervescent or soluble acetaminophen tablets dissolve in water before you drink them, and they typically contain a significant amount of sodium as part of the formulation. Sodium is one of the most well-established dietary drivers of blood pressure, so taking a high-sodium medication several times a day adds a blood pressure insult on top of whatever the acetaminophen molecule itself is doing.
Sodium-containing acetaminophen formulations have been specifically flagged as carrying increased cardiovascular risk.4Lippincott Williams & Wilkins. Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, and Hypertension If you have high blood pressure and prefer effervescent painkillers for ease of swallowing or faster absorption, switching to a standard tablet or capsule formulation eliminates the sodium issue while still giving you the same drug. It is a small change that removes an unnecessary contributor to elevated pressure.
What Researchers Still Do Not Know
The PATH-BP trial was well designed, but it was short. Two weeks of dosing is enough to detect a blood pressure change, but it does not tell us what happens over months or years of continuous use. Does the blood pressure effect persist at the same magnitude, or does it worsen? Does it fully reverse when the drug is stopped? The crossover design of the trial suggests reversal during the washout period, but long-term data are still needed.
There is also limited evidence on whether the blood pressure effect varies by dose. The trial used 4 grams per day, which is the maximum recommended daily intake. Many chronic users take lower doses, perhaps 1 or 2 grams per day. Whether the blood pressure increase scales proportionally with dose, or whether there is a threshold below which it does not occur, has not been established in a controlled trial. Some researchers suspect a dose-response relationship exists, but without trial data, it is an educated guess.
Another open question is whether the effect differs between people who already have high blood pressure and those who start with normal readings. The PATH-BP trial enrolled only hypertensive patients, so the findings are directly applicable to that group. It is plausible that the same mechanism operates in normotensive individuals, just from a lower starting point, but that has not been tested rigorously. And the clinical significance of a 5 mmHg bump is very different depending on where you start. For someone sitting at 115/75, it is unlikely to matter. For someone at 138/88, it could push them into a higher risk category.
The mechanisms behind the blood pressure effect also remain incompletely mapped. Multiple pathways have been proposed, including prostaglandin suppression, oxidative stress, and renal sodium handling, but isolating which one drives the effect in living humans is difficult. Understanding the mechanism matters because it could eventually help identify who is most susceptible and whether certain co-medications might blunt the effect. For now, the practical takeaway runs ahead of the mechanistic understanding: the drug raises blood pressure in people with hypertension, and that is worth knowing regardless of which molecular pathway is responsible.